siRNA knockdown of ADAM-10, but not ADAM-17, significantly reduces fractalkine shedding following pro-inflammatory cytokine treatment in a human adult brain endothelial cell line

HURST, Louise A., BUNNING, Rowena, SHARRACK, Basil and WOODROOFE, Nicola (2012). siRNA knockdown of ADAM-10, but not ADAM-17, significantly reduces fractalkine shedding following pro-inflammatory cytokine treatment in a human adult brain endothelial cell line. Neuroscience Letters, 521, 52-56.

Full text not available from this repository.
Official URL: http://dx.doi.org/10.1016/j.neulet.2012.05.057
Link to published version:: 10.1016/j.neulet.2012.05.057

Abstract

Fractalkine shedding is believed to occur constitutively and following induction via the activity of two membrane-bound enzymes, ADAM-10 and ADAM-17, respectively. However, our previous work suggested that ADAM-17 is not involved in the proteolytic release of fractalkine under TNF treatment of a human adult brain endothelial cell line, hCMEC/D3. The pro-inflammatory cytokine, TNF, has previously been shown to be expressed in the perivascular cuffs in multiple sclerosis. Here we sought to identify, using siRNAs to silence the expression of ADAM-10 and ADAM-17, whether ADAM-10 is responsible for TNF-induced shedding of fractalkine from the cell membrane in hCMEC/D3. Our findings suggest that ADAM-10, and not ADAM-17, is the major protease involved in fractalkine release under pro-inflammatory conditions in this human adult brain endothelial cell model.

Item Type: Article
Research Institute, Centre or Group: Biomedical Research Centre
Identification Number: 10.1016/j.neulet.2012.05.057
Depositing User: Rebecca Jones
Date Deposited: 12 Jun 2012 10:38
Last Modified: 21 Mar 2013 12:14
URI: http://shura.shu.ac.uk/id/eprint/5361

Actions (login required)

View Item

Downloads

Downloads per month over past year

View more statistics